Clinical trial
Pilot Study of the Utility of Empiric Antibiotic Therapy for Suspected…
NCT00438269 · Canadian Critical Care Trials Group, Other · Completed
Key facts
| NCT number | NCT00438269 |
|---|---|
| Title | Pilot Study of the Utility of Empiric Antibiotic Therapy for Suspected ICU-Acquired Infection |
| Official title | Appropriate Antimicrobial Therapy in Critical Care: A Pilot Randomized Controlled Trial |
| Lead sponsor | Canadian Critical Care Trials Group, Other |
| Collaborators | The Physicians' Services Incorporated Foundation |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Nosocomial Infection, Pneumonia, Systemic Inflammatory Response Syndrome, Critical Illness, Pyrexia |
| Intervention type | Drug |
| Interventions | Site-specific empiric regimens included: Meropenem, Piperacillin/tazobactam, Ciprofloxacin and cefazolin +/- metronidazole |
| Enrollment | 80 |
| Start date | Feb 1, 2003 |
| Completion | Mar 1, 2005 |
| First posted | Feb 22, 2007 |
| Last update posted | Feb 22, 2007 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: